1.46
Scisparc Ltd Aktie (SPRC) Neueste Nachrichten
Is SciSparc Ltd. stock oversold or undervaluedChart Signals & Low Drawdown Momentum Ideas - ulpravda.ru
Breakout Zone: How SciSparc Ltd stock benefits from global expansionJuly 2025 Intraday Action & Growth Focused Investment Plans - moha.gov.vn
Published on: 2026-01-09 12:53:14 - ulpravda.ru
Why SciSparc Ltd. stock remains on watchlistsJuly 2025 WrapUp & Growth Focused Stock Reports - ulpravda.ru
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why SciSparc Ltd. stock is seen as undervalued2025 Market Sentiment & Growth-Oriented Investment Plans - ulpravda.ru
Neurothera Labs Announces Results of AGM - TheNewswire
VIX Spike: Why SciSparc Ltd. stock remains a top recommendationJuly 2025 Outlook & Free Fast Gain Swing Trade Alerts - ulpravda.ru
How strong is SciSparc Ltd. stock revenue growthMarket Sentiment Report & AI Enhanced Trading Alerts - ulpravda.ru
Why SciSparc Ltd. stock remains a top recommendation2025 Growth vs Value & Daily Chart Pattern Signals - ulpravda.ru
Can SciSparc Ltd. stock deliver strong Q4 earningsStop Loss Placement Tips & Small Investment Capital Tips - ulpravda.ru
What drives SciSparc Ltd stock priceHigh Dividend Yield Stocks & Small Budget Capital Growth - Early Times
Libord Securities Limited Testing Reversal Zone on Weekly ChartMarket Sentiment Report & Outstanding Investment Returns - earlytimes.in
What analysts say about SciSparc Ltd stockStock Correlation Metrics & Daily Tips From Top Market Analysts - earlytimes.in
SciSparc says Neurothera Labs granted patent by Israeli Patent Office - MSN
SciSparc Calls February 2026 Meeting to Approve New Deloitte Auditor and Executive Equity Awards - TipRanks
SciSparc’s subsidiary NeuroThera receives patent in Israel for opioid tech By Investing.com - Investing.com Nigeria
SciSparc’s subsidiary NeuroThera receives patent in Israel for opioid tech - Investing.com India
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects - The Manila Times
SciSparc Ltd.'s Majority-Owned NeuroThera Labs Receives Patent for Opioid-N-acylethanolamine Combination to Enhance Pain Management - Quiver Quantitative
SciSparc: Neurothera Labs Granted Patent by Israeli Patent - GlobeNewswire
New opioid drug combo is patented for strong pain relief with fewer side effects - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aug Catalysts: How SciSparc Ltd stock benefits from global expansionDividend Hike & High Accuracy Buy Signal Tips - moha.gov.vn
CEO Moves: Is Venture Global Inc. stock a good choice for value investorsJuly 2025 Trade Ideas & Risk Controlled Swing Alerts - moha.gov.vn
Aug Drivers: Is SciSparc Ltd stock oversold or undervaluedMarket Risk Summary & High Conviction Buy Zone Picks - moha.gov.vn
Market Wrap: Is SciSparc Ltd. stock oversold or undervaluedWeekly Gains Report & Verified Momentum Stock Ideas - moha.gov.vn
SciSparc (SPRC) Stock Price, Quote, News & History - Benzinga
Is SciSparc Ltd. stock a smart buy before Fed meetingJuly 2025 PostEarnings & Low Risk Entry Point Guides - DonanımHaber
Why analysts remain bullish on SciSparc Ltd. stockAnalyst Downgrade & Weekly Return Optimization Plans - DonanımHaber
SciSparc Ltd. Announces $2.2 Million Securities Offering - MSN
SciSparc gets Nasdaq extension to regain compliance - MSN
Scisparc Ltd (SPRC) - MSN
SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech - MSN
SciSparc Shares Experience Pre-Bell Dip Following Quiet Session - timothysykes.com
SciSparc (SPRC) Stock on December 5, 2025: Price Action, Quantum Data Deal, GERD Device Pivot and 2030 Forecast - ts2.tech
Will SciSparc Ltd. stock outperform growth indexesJuly 2025 Final Week & Growth-Oriented Investment Plans - Newser
NeuroThera to acquire 55% stake in quantum computing bio data company - MSN
SciSparc Shares Slide After Revealing Plans to Acquire MUSE Endoscopic System IP - MSN
SciSparc’s NeuroThera Labs Eyes Quantum Leap with New Acquisition - TipRanks
SciSparc Ltd. Announces NeuroThera Labs' Planned Acquisition of Quantum Computing Bio Data Company - Quiver Quantitative
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company - The Manila Times
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):